Kestra Advisory Services’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.36K Buy
28,500
+12,500
+78% +$19.6K ﹤0.01% 3106
2025
Q4
$49.6K Hold
16,000
﹤0.01% 3941
2025
Q3
$42.1K Buy
+16,000
New +$35.3K ﹤0.01% 2868

Other funds holding GOSS

Kestra Advisory Services's GOSS Position: Q1 2026 in Review

Kestra Advisory Services increased its Gossamer Bio (GOSS) stake by 78% in Q1 2026, buying an estimated $19.6K and bringing the position to 28,500 shares worth $9.36K. The position accounts for ﹤0.01% of the portfolio, ranked #3106.

Kestra Advisory Services first reported a position in GOSS in Q3 2025 and has held it in 3 quarters since. The position peaked at $49.6K in Q4 2025. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Kestra Advisory Services held 28,500 shares of Gossamer Bio worth $9.36K as of Q1 2026.
  • Kestra Advisory Services bought 12,500 Gossamer Bio shares in Q1 2026, an estimated $19.6K.
  • Gossamer Bio made up ﹤0.01% of Kestra Advisory Services's portfolio in Q1 2026, its #3106 holding.
  • Kestra Advisory Services first reported a position in Gossamer Bio in Q3 2025 and has held it in 3 quarters since.
  • Kestra Advisory Services's Gossamer Bio position peaked at $49.6K in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.